Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
6 studies found for:    Open Studies | "Hemorrhagic Fever, Ebola"
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Hemorrhagic Fever, Ebola" (6 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Not yet recruiting A Prospective, Open Label, Observational Phase 1 Safety Study of Passive Immune Therapy During Acute Ebola Virus Infection Using Transfusion of INTERCEPT Plasma Prepared From Volunteer Donors Who Have Recovered From Ebola Virus Infection
Condition: Acute Ebola Virus Infection
Intervention: Biological: INTERCEPT Plasma
2 Recruiting Phase I Trial to Assess the Safety, Tolerability and Immunogenicity of a Ebola Virus Vaccine (rVSVΔG-ZEBOV-GP)
Condition: Hemorrhagic Fever, Ebola
Intervention: Biological: rVSVΔ-ZEBOV-GP
3 Not yet recruiting A Study to Find Out if the New Ebola Vaccine is Safe and Stimulates Immunity That Might Protect Adults in Kilifi, Kenya.
Condition: Ebola Virus Disease
Intervention: Biological: VSV-ZEBOV
4 Recruiting Phase 1 Trial of Ebola Vaccine in Mali
Conditions: Ebola Virus Disease;   Hemorrhagic Fever
Intervention: Biological: Ebola Chimpanzee Adenovirus Vector Vaccine (cAd3-EBO Z)
5 Not yet recruiting An Open-Label, Multicenter Study of the Safety and Anti Viral Activity of Brincidofovir (BCV, CMX001) for Ebola Virus Disease
Condition: Ebola Virus
Intervention: Drug: CMX001
6 Recruiting Safety, Tolerability, and Immunogenicity of the Ebola Chimpanzee Adenovirus Vector Vaccine (cAd3-EBO), VRC-EBOADC069-00-VP, in Healthy Adults
Condition: Healthy Adult Immune Responses to Vaccine
Interventions: Biological: VRC-EBOADC069-00-VP;   Biological: VRC-EBOADC076-00-VP

Indicates status has not been verified in more than two years